Janssen Sciences Ireland UC

Politician(s) lobbied: Jack Chambers (Minister of State), Department of Public Expenditure, NDP Delivery and Reform

Intent: To inform the Minister about J&J's economic footprint in Ireland and the complexity of global supply chains.::To outline the potential impact of tariffs and to avoid reciprocal tariffs.::To improve patient access to new medicines in Ireland.::To highlight the potential for digitalisation in the health service and how this would support the introduction of future therapies.::To advance the national life sciences strategy and adopt a coordinated approach to economic, health, and EU policy.

Methods: Meeting

Politician(s) lobbied: Shane Moynihan (TD), Dáil Éireann, the Oireachtas; Pádraig O'Sullivan (TD), Dáil Éireann, the Oireachtas; Ged Nash (TD), Dáil Éireann, the Oireachtas

Intent: To highlight challenges to patient access to new medicines in Ireland::To encourage improvements to the assessment and reimbursement system for innovative medicinal products in Ireland in order to speed up patient access

Methods: Informal communicationMeeting

Politician(s) lobbied: Simon Harris (Tánaiste and Minister), Department of Foreign Affairs

Intent: To raise awareness of challenges to patient access to new medicines in Ireland::To improve patient access to new medicines by improving the speed and efficiency of the medicines assessment and reimbursement process

Methods: Informal communication

Politician(s) lobbied: Stephen Mulvany (Chief Financial Officer), Health Service Executive

Intent: To improve patient access to innovative medicinal products in Ireland::To encourage the commencement of discussions between the innovative pharmaceutical industry and the State on a new framework agreement on patient access and medicines reimbursement

Methods: Informal communication

Politician(s) lobbied: Albert Dolan (TD), Dáil Éireann, the Oireachtas

Intent: To promote the adoption of a holistic national life sciences sector strategy by the Government::To improve patient access to innovative medicinal products in Ireland

Methods: EmailSubmissionMeeting

Politician(s) lobbied: Simon Harris (Tánaiste and Minister), Department of Foreign Affairs; Joe Hackett (Assistant Secretary), Department of Foreign Affairs

Intent: To increase policy focus on Ireland's competitiveness as a location for the biopharmaceutical industry::To improve patient access to innovative medicinal products in Ireland

Methods: Meeting

Politician(s) lobbied: Declan Hughes (Secretary General), Department of Enterprise, Trade and Employment; John Newham (Assistant Secretary), Department of Enterprise, Trade and Employment

Intent: To adopt a holistic national strategy for the life sciences sector in Ireland which aims to realise benefits both to economic development and public health.

Methods: Informal communication

Politician(s) lobbied: Billy Kelleher (MEP), European Parliament; Cynthia Ní Mhurchú (MEP), European Parliament; Seán Kelly (MEP), European Parliament; Nina Carberry (MEP), European Parliament

Intent: To promote Irish input into the development of the EU Strategy for the Life Sciences in 2025.::To support pharmaceutical innovation and competitiveness at European level by maintaining the existing baselines of IP and incentives for new medicines in the context of the revision of the general pharmaceutical legislation.

Methods: Informal communicationMeeting

Politician(s) lobbied: Robert Watt (Secretary General), Department of Health

Intent: To adopt a holistic national strategy for the life sciences sector which aims for both public health and economic benefits.::To protect the existing IP baselines and incentives framework in the context of the revision of the EU pharmaceutical legislation.::To improve speed of patient access to new medicines in Ireland.

Methods: Informal communicationEmailSubmission

Politician(s) lobbied: Jennifer Carroll MacNeill (Minister), Department of Health; Peter Burke (Minister), Department of Enterprise, Trade and Employment; Thomas Byrne (Minister of State), Department of Foreign Affairs

Intent: To introduce new Ministers to J&J and highlight its positive contribution to public health and the Irish economy.::To advance the adoption of a holistic national strategy for the life sciences sector, aiming for benefits both to public health and economic development.::To welcome the Government commitment to achieve patient access as quickly as possible and to reduce the timelines for patients in Ireland to access innovative medicines through reform of the reimbursement system.::To establish a platform for ongoing stakeholder collaboration with Government on medicines reimbursement.::To welcome the Government's commitment to support IP rights for medicines to drive innovation and competitiveness and to request that this be reflected in Irish positions at European level.

Methods: Informal communicationLetter